openPR Logo
Press release

Healthcare CMO Market is Projected to Report a CAGR of 14.30% between 2013 and 2019

08-29-2018 08:29 AM CET | Health & Medicine

Press release from: Transparency Market Research

Transparency Market Research

Transparency Market Research

Increasing competition in the healthcare sector has impelled major companies to concentrate on the reformation of their business strategies along with the emphasis on product manufacturing, development, design, and marketing, reports Transparency Market Research in a new study. In this regard, contract manufacturing outsourcing has become a major need for the manufacturers of pharmaceuticals and medical devices as they strive to retain their position in the market. The top three companies in the global healthcare CMO market acquire approximately 17.2% of the global revenue with Catalent Pharma Solutions Inc. leading. The company was trailed by Lonza Group and Boehringer Ingelheim GmbH.

As the global healthcare CMO market is extremely fragmented with only a few companies dominating the market, the leading companies in this segment have taken up dominant competitive strategies, strong acquisition strategies, and high product development to maintain their lead in the market. Due to the availability of similar technologies and low product differentiation, the competitive rivalry in the market is expected to rise. Moreover, leading companies are investing on research and development projects to maintain a high level of competitive rivalry.

Report Overview @ https://www.transparencymarketresearch.com/healthcare-cmo-market.html

Patent Expirations of Drugs to Adversely Impact Demand for Healthcare CMOs

In the next few years, several renowned drugs are getting off patent leading to an increase in competition among developers of drugs. Innovative drug developers are collaborating with contract manufacturing organizations to minimize the risk of heavy competition from generic drug developers due to the increasing healthcare R&D cuts by federal banks. The degeneration in the productive outcomes of R&D and the rising inquiry from regulatory bodies during the approval process of drugs has led to a substantial increase in the demand for CMOs as several leading pharmaceutical companies have started outsourcing their drug development activities.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2452

Furthermore, the need for product innovation and post engineering support service impelled manufacturers to outsource activities such as design, validation, prototype, feasibility tests, concept, and regulatory compliance. Thus, leading companies are seeking synergy with CMOs as a result of patent expirations and decreasing R&D budget.

Emerging Economies to Provide Opportunities for the Development of CMOs in Healthcare Sector

Countries such as India, China, and Brazil are emerging as key participants in the global pharmaceutical and medical device market as they own plentiful expertise and technologies for research and development. They also back medical giants in their respective research projects regarding lifesaving drugs and advanced therapies. Thus, these countries are expected to emerge as the major destinations for the outsourcing of medical device and pharmaceuticals. Global pharmaceutical companies consider these countries to be efficient for research centers and clinical trials. Various CMOs operating outside Asia have successfully attained FDA approvals and credibility for quality standards. The sanction of Good Manufacturing Practice certificates in emerging economies, especially in Asia, has led to a substantial growth of the healthcare CMO market.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2452

Delayed Delivery of Supplies Could Dent Business Flow to CMOs

The three most important rules of the medical device and pharmaceutical industry are time to market, time to volume and time to profit. The failure of these can lead to the decline in customer satisfaction and manufacturer competitiveness. Due to the rise in the cost of research and development projects and absence of proper infrastructure and trained workforce, the pharmaceutical companies fail to diversify their product portfolio leading to a delay in supply delivery. Thus, the failure to deliver supplies on time is expected to hamper the growth of the contract manufacturing organizations market.

North America is projected to lead the global market for healthcare CMO with 32.9% followed by Asia-Pacific with a share of 31.2%. The global healthcare CMO market is anticipated to rise at a CAGR of 14.30% between 2013 and 2019 with a market worth of US$246.5 bn by the end of 2019 from a value of US$97.6 bn in 2012.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Healthcare CMO Market is Projected to Report a CAGR of 14.30% between 2013 and 2019 here

News-ID: 1208034 • Views: 142

More Releases from Transparency Market Research

Subsea Well Access System Market In-depth qualitative insights, historical data, …
Global Subsea Well Access System Market: Overview The global subsea well access system market is primarily driven by plummeting production from the oil and gas reserves together with ageing offshore fields. A quick shift toward subsea regions is the emerging trend in oil and gas production sector, marking an important divergence from the usual methods of production. Some of the subsea environment exists in most unexplored and extremely remote parts of
Nicotinic Acid Market Size, Share, Growth, Trends, and Forecast 2027
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the Nicotinic Acid Market for the 2019-2027 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the Nicotinic Acid Market over
1 – Decene Market Growth Analysis, Share, Demand By Regions 2027
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the 1 – Decene Market for the 2019-2027 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the 1 – Decene
Steep Slope Roofing Materials Market Analysis, Size, Share, Growth, Trends, and …
Overview The research report provides valuable insights into demand drivers, geographical outlook, and competitive landscape of the 1 – Decene Market for the 2019-2027 forecast period. Further, it throws light on restraints as well discusses opportunities at length that are likely to come to the fore over the forecast period. The analysis thus provided helps Market stakeholders with business planning and to gauge scope of expansion in the 1 – Decene

All 5 Releases


More Releases for CMO

PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - …
PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition Where's your place in the CMO hierarchy? Find out in the CMO industry's authoritative analysis of manufacturing of NDA approvals. This CMO scorecard was compiled through hundreds of professional hours of research and analysis, and is presented in a 40-page report with over 30 graphs and tables. Only CMO Scorecard enables the CMO industry to benchmark its performance
Bio CMO Market Forecast Report Analysis || MarketReportsOnline.com
The report entitled “Global Bio CMO Market: Size, Trends & Forecasts (2018-2022)”, provides analysis of the global bio CMO market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the global biologics market by value, by top selling products, etc. Complete report available at http://www.marketreportsonline.com/711298.html. Growth of the overall global bio CMO market has been forecasted for
CMO Scorecard Market: Outsourcing of NDA Approvals and CMO Performance
Latest industry research report on: CMO Scorecard Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Find out in the CMO industrys authoritative analysis of manufacturing of NDA approvals. This CMO scorecard was compiled through hundreds of professional hours of research and analysis, and is presented in a 40-page report with over 30 graphs and tables. Only CMO Scorecard enables the CMO industry to benchmark its
Global Healthcare CMO Market (2017-2021 Edition)
This report named Global Healthcare CMO Market (2017-2021 Edition), analysis the growth and sizing of global healthcare CMO market and its segments. This report provides the analysis of global healthcare CMO market by value and by segment. View Full Report at: https://www.marketresearchreports.biz/reports/1208755/global-healthcare-cmo-edition-market-research-reports The analysis of global medical device CMO market is done by value, by players and by cost structure and analysis of global pharmaceutical CMO is done by value and
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report. Request
CMO Scorecard Review: CMO Performance & Outsourcing of NDA Approvals 2017
Recently, Market Research Hub (MRH) has added a fresh report which focuses on the CMO industry’s authoritative analysis of manufacturing of NDA approvals. The research report focusing on the CMO Scorecard and is titled as, “PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition”. This CMO scorecard was assembled through hundreds of professional hours of research and analysis, and is comprised in a 40-page report. Request